RxDoctor Payments Data

Ramin Tabaddor, MD

Orthopaedic Surgery · East Greenwich, RINPI 1548294291

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $9,250 of the $12,994 with a category attached, or 71.2%. Arthrex accounts for 74.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $6,517 and has fallen 98.6% since, to $93 in 2025.

$12,994in general payments, 2019–2025

Across 24 payments — averaging $541.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$10K
  • Kairos Surgical Inc$3K
  • Smith+Nephew$190
  • Stryker$110
  • Bioventus LLC$19
  • Pacira Therapeutics, Inc.$11

What the payments were for

  • Speaking & faculty fees$9,25071%
  • Travel & lodging$1,96615%
  • Food & beverage$5774%
  • Education$1,2009%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,994 in reported general payments places this provider in the 70th percentile of 124 orthopaedic surgery providers in Rhode Island.

See all orthopaedic surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$76,781
Medicare patients
247
Services billed
1,017

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam127$528
Prednisone28$124

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in East Greenwich

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →